Jula Inrig

CHIEF MEDICAL OFFICER · 4 filings · Latest: May 4, 2026

Travere Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	May 6, 2026	Sale	$43.95	311	$13.7K	113,238	May 7 12:00 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	May 5, 2026	Sale	$46.65	2,174	$101.4K	113,549	May 7 12:00 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	May 4, 2026	Sale	$45.00	20,000	$900.0K	111,473	May 7 12:00 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	May 4, 2026	Option Exercise	$18.47	24,250	$448.0K	115,723	May 7 12:00 AM
TVTX	JULA INRIG	—	May 6, 2026	Proposed Sale	$43.95	311	$13.7K	—	May 6 8:02 PM
TVTX	Jula Inrig	—	May 5, 2026	Proposed Sale	$46.65	2,174	$101.4K	—	May 5 11:31 PM
TVTX	JULA INRIG	—	May 4, 2026	Proposed Sale	$45.00	20,000	$900.0K	—	May 4 8:03 PM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	Apr 15, 2026	Sale	$42.61	1,018	$43.4K	111,473	Apr 16 1:46 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	Apr 14, 2026	Sale	$41.93	7,215	$302.5K	112,491	Apr 16 1:46 AM
TVTX	JULA INRIG	—	Apr 15, 2026	Proposed Sale	$42.61	1,018	$43.4K	—	Apr 15 8:13 PM
TVTX	Jula Inrig	—	Apr 14, 2026	Proposed Sale	$41.93	7,215	$302.5K	—	Apr 15 12:53 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	Feb 4, 2026	Sale	$32.21	1,779	$57.3K	105,706	Feb 5 9:05 PM
TVTX	JULA INRIG	—	Feb 4, 2026	Proposed Sale	$32.21	1,779	$57.3K	—	Feb 4 9:06 PM
TVTX	Jula Inrig	—	Feb 3, 2026	Proposed Sale	$32.12	6,956	$223.4K	—	Feb 4 2:37 AM
TVTX	Jula Inrig	CHIEF MEDICAL OFFICER	Feb 3, 2026	Sale	$32.12	6,956	$223.4K	107,485	Feb 4 2:30 AM
TVTX	JULA INRIG	—	Jan 6, 2026	Proposed Sale	$37.75	445	$16.8K	—	Jan 6 9:07 PM
TVTX	Jula Inrig	—	Jan 5, 2026	Proposed Sale	$40.18	2,031	$81.6K	—	Jan 6 12:49 AM
TVTX	JULA INRIG	—	Dec 24, 2025	Proposed Sale	$42.00	15,000	$630.0K	—	Dec 29 2:39 PM
TVTX	Jula Inrig	—	Feb 12, 2025	Proposed Sale	$23.53	2,568	$60.4K	—	Feb 13 12:46 AM
TVTX	JULA INRIG	—	Feb 4, 2025	Proposed Sale	$20.11	1,066	$21.4K	—	Feb 4 9:11 PM

Page 1 of 2